简化并优化6至59月龄儿童急性营养不良的管理:尼日尔分散地区三臂社区个体随机对照试验研究方案
该研究方案在尼日尔津德尔地区开展三臂个体随机对照非劣效试验,比较OptiMA和ComPAS两种简化方案与尼日尔标准营养方案治疗6至59月龄无并发症急性营养不良儿童的效果,主要结局为随机化后6个月的良好结局,并计算每组需567名儿童。
要点
- OptiMA和ComPAS均基于上臂围(MUAC)使用单一即用治疗食品并逐步减量。
- 主要结局为随机化后6个月时存活、未患急性营养不良且无额外急性营养不良发作。
- 样本量计算主要目标每组需567名儿童。
核心结论
- 该试验旨在生成关于简化优化急性营养不良治疗方案的必要证据,并参与达成此类营养方案的共识。
研究设计与样本
- 在尼日尔津德尔地区初级卫生中心和社区开展的非劣效个体随机对照临床试验,于2021年3月进行。
- 研究对象为6至59月龄、MUAC<125mm或水肿且无医疗并发症的就诊儿童,所有参与者随访6个月。
主要发现
- 主要结局在纳入后6个月复合定义为存活、按入组定义未患急性营养不良且6个月观察期内无额外急性营养不良发作。
- 恢复定义为随机化后6个月内至少4周治疗、腋温<37.5°C、无双足水肿且连续两周MUAC≥125mm。
- 样本量计算主要目标每组需567名儿童,次要目标在严重急性营养不良和MUAC<115mm儿童中每组分别需295名和384名儿童。
- 将对每个结局进行符合方案集和意向性治疗分析。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Simplified approaches of acute malnutrition (AM) treatment have been conducted over the past 5 years intending to unify processes and increase coverage among children aged 6 to 59 months without medical complication. The Optimsing treatment for Acute Malnutrition (OptiMA) and the Combined Protocol for Acute Malnutrition Study (ComPAS) are mid-upper arm circumference (MUAC)-based approaches treating children with MUAC < 125 mm or oedema with one sole product-ready-to-use therapeutic food-at a gradually tapered doses. This trial aims to compare the OptiMA and ComPAS strategies to the standard nutritional protocol of Niger assessed by a favourable outcome in the treatment of uncomplicated AM at 6 months post-randomisation and in terms of recovery rate after treatment of uncomplicated SAM (WHZ < - 3 or MUAC < 115mm or oedema) and among the most vulnerable children (MUAC < 115mm or oedema). METHODS: A non-inferiority individually randomised controlled clinical trial was conducted at the primary health centres level and in the community in the Zinder region in Niger in March 2021. Participants are children aged 6-59 months attending outpatient health centres with MUAC < 125mm or oedema without medical complications. All participants are followed for 6 months. Simplified strategies propose a gradual reduction of RUTF according to MUAC and weight in OptiMA and MUAC only in ComPAS. Favourable outcome is compositely defined at 6 months post-inclusion as being alive, not acutely malnourished by the definition applied at inclusion and without any additional episode of AM throughout the 6-month observation period. Recovery is defined throughout the 6 months post-randomisation by a minimum of 4-week duration of treatment, an axillary temperature < 37.5°C, an absence of bipedal oedema and a MUAC ≥ 125 mm for two consecutive weeks. The sample size calculation required 567 children per arm for the main objective, 295 and 384 children per arm for the secondary objectives among SAM and MUAC < 115 mm children, respectively. Per-protocol and intention-to-treat analyses will be conducted for each outcome. DISCUSSION: This trial is intending to generate much-needed evidence on various simplified and optimised AM treatment approaches and to participate in reaching a consensus on such nutrition protocols. TRIAL REGISTRATION: ClinicalTrials.gov NCT04698070 . Registered on January 6, 2021.
引用
- Daures M, Hien J, Phelan K, et al. Simplifying and optimising management of acute malnutrition in children aged 6 to 59 months: study protocol for a 3 arms community-based individually randomised controlled trial in decentralised Niger. Trials. 2022. PMID: 35090531. doi:10.1186/s13063-021-05955-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。